Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJohn F. Greden, Bryan Dechairo, Francis M. Mondimore et al.|Journal of Psychiatric Research|2019Cited by 346
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF)Harold A. Sackeïm, A. John Rush, Scott T. Aaronson et al.|Journal of Psychiatric Research|2019Cited by 108
(untitled)A. John Rush, R. Hamish McAllister‐Williams, Harold A. Sackeïm et al.|Newcastle University ePrints (Newcastle Univesity)|0Cited by 75
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E. Thase, John F. Greden, Sagar V. Parikh et al.|The Journal of Clinical Psychiatry|2019Cited by 72